Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
Posted
Mar 6, 2026
Due Date
Mar 11, 2026
Location
San Antonio, Texas
Description
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=bc21eb281be04db5939621849299c76a
AI Summary
The Department of Defense Defense Health Agency (DHA) is issuing RFQ HT9402‑26‑Q‑9202 to obtain price quotes for pharmaceutical agents that will be considered for inclusion on the DoW Uniform Formulary (UF). Offerors must submit separate, signed quotes for the UF Blanket Purchase Agreement (BPA) and/or the UF Additional Discount Program (ADP) using the Manufacturer Quote Submission Checklist. Quotes must reference the company’s current FSS contract number, match the company name on the VA NAC Search Tool, and be equal to or lower than the prices listed on the FSS, Big 4, and Joint National Contract (JNC) sites. All package sizes (e.g., 30, 100, 1000) must be quoted, and BPA quotes must cover every size. Offerors must also agree to work with the DoW Prime Vendor Program, open a limited distribution channel to Accredo for TRICARE mail‑order (DoW only), and provide additional discounts that are equal to or less than any existing reductions on the approved FSS or National Contract price lists. Prices must remain valid for 180 days, and any price contingencies tied to the number of agents selected for the Basic Core Formulary (BCF) or Extended Core Formulary (ECF) must be identified in the NDC price lists. Interested companies must register by emailing the RFQ point of contact, submit any advanced questions for discussion at a pre‑quotation teleconference, and may request one‑on‑one technical appointments. In lieu of a clinical presentation, offerors must answer two questions via email describing the clinical advantages of the proposed drug over competitors. All quotes submitted after the deadline may be rejected, and extensions are granted at the Contracting Officer’s discretion. The evaluation will consider both clinical effectiveness and the quoted price’s impact on relative cost‑effectiveness for UF tier classification (generic, formulary, BCF, ECF, or non‑formulary).
Details
- Notice ID
- bc21eb281be04db5939621849299c76a
- Solicitation Number
- HT9402-26-Q-9202
- NAICS Code
- 325412
- Classification Code
- 6505
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Filgrastim Biosimilar (VA-27-00012533)
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NAC PHARMACEUTICALS (36E797)
- Nutrition Care Services; Military Treatment Facilities - Forts Irwin, Leonard Wood, Riley, Stewart, and West Point
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- Epinephrine Injector
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
- 6505--General Radioisotopes (Diagnostic & Therapeutic)
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NETWORK CONTRACT OFFICE 19 (36C259)
- Notice of Intent to Sole Source the Co-sponsorship of a Forum on Traumatic Brain Injury with the National Academies of Science, Engineering, and Medicine (NASEM)
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- PANDHA-26-P-0000 046239 Security Support Services
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- 6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.242-NETWORK CONTRACT OFFICE 02 (36C242)